ACTRN12620000594921进行中（未招募）未知
Partnering with General practitioners to Optimise Survivorship for PatiEnts with Lymphoma: A Phase II randomised controlled trial on effect of shared model of follow-up care on quality of life (The GOSPEL I Trial)
Professor Raymond Chan0 个研究点目标入组 51 人开始时间: 2020年5月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Due to the varying follow-up requirements for patients with lymphoma, we will recruit 2 groups of patients who map to 2 distinct follow-up pathways:
- •-Group 1. Acute post-treatment follow-up: Patients with a pathologically confirmed diagnosis of aggressive or indolent lymphoma in the acute post-treatment phase (i.e., within three months of completion of chemotherapy); and
- •-Group 2. Observation follow-up (i.e., surveillance clinics): Patients with a pathologically confirmed diagnosis of indolent lymphoma followed up in the surveillance clinic and at least 2 years post-treatment or treatment naïve.
- •All participants must be:
- •-Men or women
- •->/=18 years of age
- •-have an ECOG performance status <2
- •-be an ambulatory patient at the time of recruitment
- •-be able to nominate a GP to be involved in their follow-up
- •-have access to a telephone
排除标准
- •-the presence of severe mental, cognitive or physical conditions that would limit the patient’s ability to participate as per treating clinician.
- •-Lymphoma not in remission
研究者
相似试验
尚未招募
不适用
Validation of Skin Field Cancerisation Index: the assessment of a solar damage severity tool for patients undergoing radiotherapy treatment for field cancerisation.Skin Cancer including Keratinocyte CarcinomasSkin - Dermatological conditionsCancer - Malignant melanomaCancer - Non melanoma skin cancerACTRN12620000056998GenesisCare150
已完成
不适用
A collaborative primary care-based approach to managing upper respiratory tract infections as a strategy to reduce antibiotic prescribingpper Respiratory Tract InfectionsRespiratoryUpper Respiratory Tract InfectionsISRCTN18154381Queen's University Belfast (UK)7,500
尚未招募
不适用
A combined, tailored pharmacist intervention with dose optimization of phosphate binding drugs to improve phosphate control in patients on dialysis.NL-OMON24286Franciscus Gasthuis and Vlietland45
尚未招募
不适用
The effect of the Collaborative Optimisation and Ordering of Medications (COOM) on prescribing safety in hospitalised patientsPrescribing ErrorMedication HarmPublic Health - Health service researchACTRN12621001724864Metro South Health124
招募中
不适用
Personalized, interdisziplinary patient pathway to cross-sector care of multimorbid patientsHeart failureI50J44N18E11E10I70.29I25I10Other chronic obstructive pulmonary diseaseType 2 diabetes mellitusChronic ischaemic heart diseaseEssential (primary) hypertensionChronic kidney diseaseType 1 diabetes mellitusDRKS00031500niversität zu Köln946